Stocks and securities in focus
| Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cellectar BioSciences Inc. | -3.660% | -13.810% | -18.468% | -7.179% | -20.614% | -80.000% | - |
| SELLAS Life Sciences Group Inc | -7.990% | -0.559% | -2.555% | -28.705% | 9.538% | -85.167% | -86.404% |
| Celsion Corp. | -29.450% | 10.577% | 1.770% | 2.679% | 93.277% | -91.434% | -94.864% |
| Beximco Pharmaceuticals Ltd. GDR | - | 0.000% | 4.673% | 14.286% | 1.818% | -51.038% | 1.818% |
| Cardiff Oncology Inc. | -2.100% | -4.630% | 6.625% | 32.561% | 56.535% | -54.222% | 35.776% |
| Vivoryon Therapeutics N.V. | -2.920% | -11.364% | 11.835% | -82.729% | -73.321% | -88.989% | -65.291% |
| Moberg Pharma AB | -6.180% | -7.547% | 13.077% | - | - | - | - |
| Eledon Pharmaceuticals Inc. | 6.400% | -1.481% | 16.667% | 121.667% | 62.195% | -50.741% | -80.294% |